HLA-C and cancer: In this study, whole-cell proteomes of 951 patients were analyzed across nine cancer types from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) resource (27), in addition to other publicly available immunopeptidome datasets, to provide the largest pan-cancer atlas of ncORFs and novel MHC-peptides.